Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials
Gilson Fernandes, Amanda Fernandes, Rhanderson Cardoso, Jorge Peñalver, Leonardo Knijnik, Raul D. Mitrani, Robert J. Myerburg, Jeffrey J. Goldberger
Topics & Concepts
MedicineEmpagliflozinInternal medicineOdds ratioHeart failureCardiologyAtrial fibrillationRandomized controlled trialSudden cardiac deathDapagliflozinPlaceboHazard ratioConfidence intervalCanagliflozinDiabetes mellitusType 2 diabetesEndocrinologyPathologyAlternative medicineDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patientsHeart Failure Treatment and Management